To include your compound in the COVID-19 Resource Center, submit it here.

NICE not recommending Eisai's lenvatinib for additional thyroid indications

The U.K.'s NICE issued draft guidance recommending against the use of

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE